World's Best Scientists 2026 revealed!
Alessandro Cozzi-Lepri

Alessandro Cozzi-Lepri

D-Index & Metrics

Microbiology

D-Index
54
Citations
11586
World Ranking
3938
National Ranking
351

Alessandro Cozzi-Lepri publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Alessandro Cozzi-Lepri sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 259 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Alessandro Cozzi-Lepri D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Alessandro Cozzi-Lepri sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 54 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Alessandro Cozzi-Lepri is a researcher affiliated with University College London in the United Kingdom. Their primary field of study is Medicine, with a focus on Infectious Diseases, Epidemiology, Hepatology, Virology, and Neurology.

They have contributed extensively to research concerning HIV/AIDS and COVID-19, with notable attention to both clinical research and long-term effects of these diseases. Their work encompasses key topics such as:

  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • HIV-related health complications and treatments

Their frequent publication venues include:

  • International Journal of Infectious Diseases
  • The Lancet Rheumatology
  • Frontiers in Immunology
  • Research Square (Research Square)
  • Intensive Care Medicine

Key recent papers by Alessandro Cozzi-Lepri cover various aspects of viral infections and their complications, especially in the context of COVID-19:

  • "Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality," 2022, Intensive Care Medicine
  • "Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study," 2021, Microorganisms
  • "Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies," 2020, Clinical Infectious Diseases
  • "Tocilizumab for severe COVID-19 pneumonia - Authors' reply," 2020, The Lancet Rheumatology
  • "Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival," 2022, Frontiers in Immunology

Collaboration is an important aspect of Cozzi-Lepri's research. Frequent co-authors include:

  • Antonella d'Arminio Monforte
  • Giovanni Guaraldi
  • Andrea Antinori
  • Marianna Meschiari
  • Stefano Busani

Best Publications

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

    Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo

  • Tocilizumab in patients with severe COVID-19: a retrospective cohort study

    Giovanni Guaraldi;Marianna Meschiari;Alessandro Cozzi-Lepri;Jovana Milic

  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  • Common genetic variation and the control of HIV-1 in humans.

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

  • Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

    Ravindra K Gupta;Andrew Hill;Anthony W Sawyer;Alessandro Cozzi-Lepri

  • Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

    Ole Kirk;Court Pedersen;Alessandro Cozzi-Lepri;Francisco Antunes

  • CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

    Cristina Mussini;Patrizia Lorenzini;Alessandro Cozzi-Lepri;Giuseppe Lapadula

  • Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.

    Giulia Marchetti;Alessandro Cozzi-Lepri;Esther Merlini;Giusi M. Bellistrì

  • Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

    Miriam Lichtner;Paola Cicconi;Serena Vita;Alessandro Cozzi-Lepri

  • Relationship between HAART adherence and adipose tissue alterations.

    Adriana Ammassari;Andrea Antinori;Alessandro Cozzi-Lepri;Maria Paola Trotta

  • Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.

    Birgit Grund;Jason V Baker;Jason V Baker;Steven G. Deeks;Steven G. Deeks;Julian Wolfson

  • Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus.

    Kazima Saira;Xudong Lin;Jay V. DePasse;Rebecca Halpin

  • Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.

    Gilbert Greub;Alessandro Cozzi-Lepri;Bruno Ledergerber;Schlomo Staszewski

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.

    Michela Violin;Alessandro Cozzi-Lepri;Rossella Velleca;Antonella Vincenti

  • Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

    Alessandro Cozzi-Lepri;Andrew N Phillips;Lidia Ruiz;Bonaventura Clotet

  • Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A. : a modelling study

    Mikaela Smit;Rachel Cassidy;Alessandro Cozzi-Lepri;Eugenia Quiros-Roldan

  • Virologic and Immunologic Response to Regimens Containing Nevirapine or Efavirenz in Combination with 2 Nucleoside Analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) Study

    Alessandro Cozzi-Lepri;Andrew N. Phillips;Antonella d'Arminio Monforte;Nicolò Piersantelli

  • Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.

    Paola Cicconi;A Cozzi-Lepri;A Castagna;E M Trecarichi

  • Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug-Naive Patients Treated with Protease Inhibitor-Based Therapy

    Carlo F. Perno;Alessandro Cozzi-Lepri;Claudia Balotta;Federica Forbici

  • Machine learning can identify newly diagnosed patients with CLL at high risk of infection.

    Rudi Agius;Rudi Agius;Christian Brieghel;Michael A. Andersen;Alexander T. Pearson

  • Common Genetic Variation and the Control of HIV-1 in Humans

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

Frequent Co-Authors

Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Andrea Antinori
Andrea Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Cristina Mussini
Cristina Mussini University of Modena and Reggio Emilia
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Andrew N. Phillips
Andrew N. Phillips University College London
Andrea De Luca
Andrea De Luca University of Siena
Carlo Federico Perno
Carlo Federico Perno University of Milan
Andrea Gori
Andrea Gori University of Milan
Antonella Castagna
Antonella Castagna Vita-Salute San Raffaele University
Roger Paredes
Roger Paredes University of Vic - Central University of Catalonia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career opportunities, many of which intersect with healthcare and information management fields. For those interested in healthcare, becoming a functional medicine np salary professional reflects the growing demand for practitioners specializing in holistic patient care. This path often requires advanced certifications and interdisciplinary knowledge that complements microbiology expertise.

Another important area is health information management. Pursuing a health information management bachelor degree salary can lead to well-paying roles managing sensitive medical data crucial for research and clinical operations related to microbiological studies.

Certification also plays a critical role in enhancing career prospects. For instance, earning a certified professional coder certification can provide specialized skills in medical coding, essential for healthcare billing and documentation—skills valued in microbiology-related healthcare environments.

To pursue these opportunities online, students should consider cahiim accredited health information management programs online, which offer flexible and credible pathways to gain expertise in health information management while integrating smoothly with microbiology career goals.

Best Scientists Citing Alessandro Cozzi-Lepri

Trending Scientists

Recently Published Articles